Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00148928
Status:
COMPLETED
Last Update Posted:
2017-06-02
First Post:
2005-09-07
Brief Title:
Safety Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasms Prostate |
Keywords: